Trump Vowed To End Surprise Medical Bills. The Office Working on That Just Got Slashed.

As President Donald Trump wrapped up his first term in 2020, he signed legislation to protect Americans from surprise medical bills. “This must end,” Trump said. “We’re going to hold insurance companies and hospitals totally accountable.” But the president’s wide-ranging push to slash government spending, led by billionaire Elon Musk, is weakening the federal office ...

Read More

Hundreds Of Stakeholders Urge Congress To Make HSA Telehealth Provision Permanent

More than 8 in 10 employers intend to offer employees and their dependents access to lower- or no-cost mental health support through their tele-mental health provider this year, the letter said.

Read More

Pfizer Could Shift Overseas Production To U.S. If Trump’s Pharma Tariffs Take Hold, CEO Says

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert Bourla, Ph.D., outlined one potential response by his company if pharmaceutical tariffs come into play. Pfizer’s local manufacturing setup is already well positioned in the U.S., and the New York-based drugmaker could bring additional resources into ...

Read More

In a sudden reversal, CDC rescinds some staff firings

Just a few weeks after summarily firing hundreds of employees, the Trump administration is now notifying some staff at the Centers for Disease Control and Prevention that they’re back on the job. On Tuesday, an unknown number of CDC staff began receiving emails stating that their letters of termination were being rescinded, according to emails reviewed ...

Read More

Potential Medicaid Cuts Could Pressure Insurers

The budget bill that was passed in the House last week calls for $2 trillion in federal spending cuts to be identified over the next decade, with $880 billion of that coming from the Energy and Commerce Committee's jurisdiction, which includes the Medicaid program.

Read More

Drugmakers Increase Prescription Med Prices in 2025

Prescription drug manufacturers raised prices on nearly 600 drugs in January, according to an analysis by 46brooklyn Research. Among those medications impacted by the increases are drugs used to treat diabetes, HIV, COVID-19, and cancer, as well as other conditions.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square